Drooid Logo
Back to story perspectives

Full Breakdown

Delayed ADHD Diagnosis in Women: A Growing Concern

10/14/2025, 10:44:57 AM

Research Findings on Gender Disparities in ADHD Diagnosis

Recent research presented at the 38th European College of Neuropsychopharmacology Annual Congress reveals that women are diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) approximately five years later than men, despite exhibiting symptoms at similar ages. The study, led by Dr. Silvia Amoretti from Barcelona, analyzed a clinical sample of 900 adults (54.9% male, 45.1% female, average age 36.94) newly diagnosed with ADHD. Results indicated that women received their diagnosis at an average age of 28.96 years, while men were diagnosed at 24.13 years. This delay is linked to more severe symptoms and higher rates of comorbid conditions such as depression and anxiety in women by the time they are diagnosed.

Implications of Late Diagnosis

The delay in diagnosis for women with ADHD can lead to significant negative outcomes, including increased emotional and functional difficulties. Dr. Amoretti noted that women often face worse clinical outcomes, which may include heightened levels of anxiety and depression, as well as impaired daily functioning. In contrast, men were found to be three times more likely to encounter legal issues related to their ADHD symptoms. The findings underscore the need for improved understanding and recognition of ADHD symptoms in women, which often manifest differently than in men.

The Role of Symptom Presentation

Experts suggest that the differences in symptom presentation between genders contribute to the diagnostic delay. Boys typically exhibit more overt hyperactive or impulsive behaviors, making their ADHD easier to identify. Conversely, girls often display inattentive traits that are less disruptive and, therefore, more likely to be overlooked. Professor Sandra Kooij from Amsterdam UMC emphasized that limited clinician awareness of ADHD in women and hormonal influences also play a role in this disparity.

Criticism & Opposition

Critics argue that the current diagnostic criteria and societal perceptions of ADHD may not adequately account for the subtler manifestations of the disorder in women. This oversight can lead to misdiagnosis or delayed treatment, as many women may be misidentified as having other conditions, such as borderline personality disorder. The need for sex-sensitive diagnostic tools and earlier screening processes is increasingly recognized as essential for improving outcomes for women with ADHD.

Official Statements & Responses

Dr. Amoretti stated, “We believe that a better understanding of these sex-based differences might improve diagnosis and treatment.” She highlighted the importance of increasing awareness in both society and the medical community to facilitate earlier intervention for women. Professor Kooij echoed this sentiment, advocating for greater awareness to ensure that girls and women receive timely support.

Verbatim Quotes

  • “ADHD affects millions of people, but our understanding of how it presents and impacts males and females differently remains limited.” — Dr. Silvia Amoretti, Lead Researcher
  • “This delay may lead to worse clinical outcomes, including depression, anxiety, and functional impairment.” — Dr. Silvia Amoretti
  • “Clinically, this means women are not treated early enough and are sometimes not diagnosed at all.” — Professor Sandra Kooij, Amsterdam UMC

What's Next

The findings from this research call for a reevaluation of ADHD diagnostic practices, particularly concerning gender differences. Future efforts may focus on developing more effective screening tools and increasing awareness among healthcare providers to ensure timely and accurate diagnoses for women.